GlassScriptPhysician profile
Jason A Mehling
NPI 1639127574
$4,002.63
in general payments reported to CMS, 2019-2025
36 companies · $967 in 2025
The $967 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $487 · 2020: $108 · 2021: $93.66 · 2022: $753 · 2023: $773 · 2024: $822 · 2025: $967.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,561.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $595.17 | 2020-2025 | Enhertu, Imfinzi, Tagrisso |
| Merck Sharp & Dohme LLC | $443.45 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $364.36 | 2019-2025 | |
| Eisai INC. | $314.06 | 2019-2025 | |
| Stryker Corporation | $267.69 | 2025 | Flowtriever, Optablate, Clottriever Bold Catheter |
| Inari Medical, INC. | $265.57 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $251.92 | 2019-2023 | Opdivo |
| Exelixis INC. | $247.90 | 2022-2023 | Cabometyx |
| Seagen INC. | $162.93 | 2019-2023 | Padcev |
| Penumbra, INC. | $124.96 | 2022-2023 | Indigo System |
| Incyte Corporation | $85.11 | 2019-2022 | |
| Pharmacyclics LLC, An Abbvie Company | $79.75 | 2019-2023 | Imbruvica |
| Karyopharm Therapeutics INC. | $77.54 | 2025 | Xpovio |
| Janssen Biotech, INC. | $63.86 | 2025 | Rybrevant, Akeega, Erleada |
| Pfizer INC. | $59.32 | 2019-2024 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $54.57 | 2024-2025 | |
| Terumo Medical Corporation | $45.21 | 2022-2024 | Angio-Seal |
| Takeda Pharmaceuticals U.S.A., INC. | $40.53 | 2019-2021 | |
| Glaxosmithkline, LLC. | $34.70 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $33.64 | 2024 | Libtayo |
| Mirati Therapeutics, INC. | $30.42 | 2024 | Krazati |
| Geron Corporation | $29.96 | 2024 | Rytelo |
| Bard Peripheral Vascular, INC. | $28.15 | 2024 | Trek |
| Beigene USA, INC. | $27.98 | 2024 | Brukinsa |
| Sirtex Medical INC | $26.91 | 2024 | Lava Les (Liquid Embolic System) |
| Z-Medica, LLC | $26.26 | 2020 | |
| Alexion Pharmaceuticals, INC. | $24.99 | 2019 | |
| Sobi, INC | $24.99 | 2024 | |
| Servier Pharmaceuticals LLC | $24.98 | 2025 | |
| Gilead Sciences, INC. | $24.97 | 2023 | Trodelvy |
| Cti Biopharma Corp. | $24.97 | 2023 | Vonjo |
| Celgene Corporation | $22.82 | 2019 | |
| Cordis US Corp. | $21.57 | 2023 | Mynx Control |
| Boston Scientific Corporation | $19.70 | 2023 | |
| Siemens Medical Solutions USA, INC. | $16.42 | 2022 | |
| Cardinal Health 200 LLC | $15.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Mehling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.